Filing metadata

Accession number
0001104659-22-003317
Form type
Form 4
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Jan 11, 2022
Reporting period
Jan 10, 2022
Description
Insider transaction

Explore SEC Filings Hub